Skip to main content

Table 1 (abstract A5). Study characteristics

From: Novelties in Sport Sciences

Study

N

Study design

Supplementation protocols

Outcome

Ostojic et al. [1]

48

RCT

GAA (1.2 a, 2.4 b, or 4.8 c gr/d) or placebo d for 6 weeks

Handgrip strength ↑ a, b, c

1 RM Bench press ↑ a, b, c

Vertical jump ↔ a, b, c, d

Anaerobic power ↔ a, b, c, d

Aerobic capacity ↔ a, b, c, d

Semeredi et al. [2]

14

RCCT

1 gr of GAA and 3 gr of creatine/d a or

4 gr/d of creatine for 4 weeks b

Total creatine ↑ a, b

Brain creatine ↑ a, b

1RM Bench press ↑ a, b

tHcy (μmol/L) ↔ a

VO2max ↔ a, b

Ostojic et al. [3]

24

RCT

GAA (2.4 gr/d) a or placebo b by oral administration for 6 weeks

Serum GAA ↑ a

Serum creatine ↑ a

Serum creatinine ↑ a

Serum tHcy ↑ a

Serum AST↔ a, b

Ostojic et al. [4]

24

RCT

2·4 gr GAA/d a, or 2·4 gr/d of GAA with 1·6 gr/d of betaine hydrochloride, 5 mg/d of vitamin B12, 10 mg/d of vitamin B6, and 600 mg/d of folic acid b

Serum creatine ↑ a, b

Serum tHcy ↑ a, ↔ b

Ostojic et al. [5]

48

RCT

GAA (1.2 a, 2.4 b, or 4.8 c gr/d) or placebo (Inulin) d for 6 weeks

Serum GAA ↑ a, b, c

Serum creatine ↑ a, b, c

Serum creatinine ↑ a, b, c

Vitamin B6, B12 ↔ a, b, c, d

tHcy (μmol/L) ↔ a, b, d; ↑ c

Ostojic et al. [6]

n=10

UINT

2 gr of GAA and 2 gr of creatine/d for 4 weeks

tHcy (μmol/L) ↑

  1. Legend: N – participants, RCT- Randomized, double-blind control trail, RCCT- Randomized, double-blind crossover trail, UINT - Uncontrolled interventional trial, GAA - Guanidinoacetic acid, tHcy- total homocysteine; ↑- increased; ↔ no change; gr/d- grams per day; Asterix a, b, c, d - represents different study groups